GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | +27.8% | 1,054 | +30.1% | 0.01% | +50.0% |
| Q4 2021 | $36,000 | -14.3% | 810 | -27.0% | 0.01% | -33.3% |
| Q3 2021 | $42,000 | +50.0% | 1,110 | +58.6% | 0.01% | +28.6% |
| Q2 2021 | $28,000 | +12.0% | 700 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $25,000 | -3.8% | 700 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $26,000 | 0.0% | 700 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $26,000 | -10.3% | 700 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $29,000 | -3.3% | 700 | -12.5% | 0.01% | -14.3% |
| Q1 2020 | $30,000 | -9.1% | 800 | +14.3% | 0.01% | +27.3% |
| Q4 2019 | $33,000 | -15.4% | 700 | -22.7% | 0.01% | 0.0% |
| Q3 2019 | $39,000 | +8.3% | 906 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $36,000 | -10.0% | 906 | -5.6% | 0.01% | -8.3% |
| Q1 2019 | $40,000 | +8.1% | 960 | -0.8% | 0.01% | -7.7% |
| Q4 2018 | $37,000 | -5.1% | 968 | +0.5% | 0.01% | 0.0% |
| Q3 2018 | $39,000 | +39.3% | 963 | +37.6% | 0.01% | -7.1% |
| Q2 2018 | $28,000 | +3.7% | 700 | 0.0% | 0.01% | -6.7% |
| Q1 2018 | $27,000 | +8.0% | 700 | 0.0% | 0.02% | +7.1% |
| Q4 2017 | $25,000 | -10.7% | 700 | 0.0% | 0.01% | -17.6% |
| Q3 2017 | $28,000 | -6.7% | 700 | 0.0% | 0.02% | -10.5% |
| Q2 2017 | $30,000 | -14.3% | 700 | -16.8% | 0.02% | -9.5% |
| Q1 2017 | $35,000 | +16.7% | 841 | +6.5% | 0.02% | +10.5% |
| Q4 2016 | $30,000 | -11.8% | 790 | 0.0% | 0.02% | -17.4% |
| Q3 2016 | $34,000 | -55.3% | 790 | -54.8% | 0.02% | -58.2% |
| Q2 2016 | $76,000 | +10.1% | 1,746 | +2.7% | 0.06% | +3.8% |
| Q1 2016 | $69,000 | -33.0% | 1,700 | -33.5% | 0.05% | -31.2% |
| Q4 2015 | $103,000 | +58.5% | 2,557 | +50.4% | 0.08% | +51.0% |
| Q3 2015 | $65,000 | +124.1% | 1,700 | +142.9% | 0.05% | +142.9% |
| Q2 2015 | $29,000 | -9.4% | 700 | 0.0% | 0.02% | -4.5% |
| Q1 2015 | $32,000 | 0.0% | 700 | -7.0% | 0.02% | -8.3% |
| Q4 2014 | $32,000 | -62.8% | 753 | -59.7% | 0.02% | -68.0% |
| Q3 2014 | $86,000 | -14.0% | 1,870 | 0.0% | 0.08% | -16.7% |
| Q2 2014 | $100,000 | +170.3% | 1,870 | +167.1% | 0.09% | +125.0% |
| Q1 2014 | $37,000 | -27.5% | 700 | -26.5% | 0.04% | +37.9% |
| Q4 2013 | $51,000 | -52.8% | 952 | -55.6% | 0.03% | -56.1% |
| Q3 2013 | $108,000 | +170.0% | 2,146 | +167.9% | 0.07% | +120.0% |
| Q2 2013 | $40,000 | – | 801 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |